Beth A. Overmoyer, MD

Article Type

Article

Changed

Mon, 03/04/2019 - 12:26

Display Headline

The role of tamoxifen in preventing breast cancer

The Breast Cancer Prevention Trial (P-1 Study)

Author(s)

Beth A. Overmoyer, MD

Article PDF

media_99be7e9_ccjm66_1-0033.pdf

Author and Disclosure Information

Beth A. Overmoyer, MD
Assistant Professor of Medicine, Case Western Reserve University School of Medicine; Director, Breast Cancer Research Program, Ireland Cancer Center, University Hospitals of Cleveland

Address: Beth A. Overmoyer, MD, Ireland Cancer Center, University Hospitals of Cleveland, 11100 Euclid Avenue, Cleveland, OH 44106

Issue

Cleveland Clinic Journal of Medicine - 66(1)

Publications

Cleveland Clinic Journal of Medicine

Page Number

33-40

Read more about The role of tamoxifen in preventing breast cancer

Sections

Interpreting Key Trials

Author(s)

Beth A. Overmoyer, MD

Author(s)

Beth A. Overmoyer, MD

Author and Disclosure Information

Beth A. Overmoyer, MD
Assistant Professor of Medicine, Case Western Reserve University School of Medicine; Director, Breast Cancer Research Program, Ireland Cancer Center, University Hospitals of Cleveland

Address: Beth A. Overmoyer, MD, Ireland Cancer Center, University Hospitals of Cleveland, 11100 Euclid Avenue, Cleveland, OH 44106

Author and Disclosure Information

Beth A. Overmoyer, MD
Assistant Professor of Medicine, Case Western Reserve University School of Medicine; Director, Breast Cancer Research Program, Ireland Cancer Center, University Hospitals of Cleveland

Address: Beth A. Overmoyer, MD, Ireland Cancer Center, University Hospitals of Cleveland, 11100 Euclid Avenue, Cleveland, OH 44106

Article PDF

media_99be7e9_ccjm66_1-0033.pdf

Article PDF

media_99be7e9_ccjm66_1-0033.pdf

The Breast Cancer Prevention Trial (P-1 Study)

Issue

Cleveland Clinic Journal of Medicine - 66(1)

Issue

Cleveland Clinic Journal of Medicine - 66(1)

Page Number

33-40